Grünenthal GmbH
Grünenthal is a global leader in pain management dedicated to changing lives for the better through innovative medicines and solutions. With a vision of a world free of pain, the company operates across the entire value chain, from research and development to commercialization, with a strong commitment to ethics, sustainability, and patient care. It has a diverse portfolio of products, a global presence with affiliates and manufacturing sites worldwide, and a focus on responsible corporate practices.
Industries
Nr. of Employees
Very Large (1000+)
Grünenthal GmbH
Mariahilfer Straße 123/TOP 341, 1060 Wien, Austria
Products
Capsaicin 8% topical patch (high‑concentration topical capsaicin)
Topical high‑concentration capsaicin patch indicated for treatment of peripheral neuropathic pain in adults; used in certain markets for postherpetic neuralgia and diabetic peripheral neuropathy of the feet.
Lidocaine topical patch
Topical lidocaine patch indicated for symptomatic relief of neuropathic pain associated with previous herpes zoster infection and other localised neuropathic pain (market dependent).
Zolmitriptan (nasal and oral formulations)
Serotonin receptor agonist formulations for acute treatment of migraine (oral and nasal formulations; nasal indicated in adolescents in some markets and for cluster headache in adults in some markets).
Testosterone undecanoate (injectable testosterone therapy)
Long‑acting testosterone replacement therapy for adult male hypogonadism confirmed by clinical features and biochemical tests.
Proton pump inhibitor (esomeprazole) formulations
Esomeprazole gastro‑resistant tablets and other formulations indicated for GERD, ulcer healing and H. pylori eradication regimens (indications vary by formulation and market).
Rosuvastatin (lipid‑lowering therapy)
Statin therapy for hypercholesterolaemia and prevention of major cardiovascular events in high‑risk patients (indications and dosing vary by market).
Capsaicin 8% topical patch (high‑concentration topical capsaicin)
Topical high‑concentration capsaicin patch indicated for treatment of peripheral neuropathic pain in adults; used in certain markets for postherpetic neuralgia and diabetic peripheral neuropathy of the feet.
Lidocaine topical patch
Topical lidocaine patch indicated for symptomatic relief of neuropathic pain associated with previous herpes zoster infection and other localised neuropathic pain (market dependent).
Zolmitriptan (nasal and oral formulations)
Serotonin receptor agonist formulations for acute treatment of migraine (oral and nasal formulations; nasal indicated in adolescents in some markets and for cluster headache in adults in some markets).
Testosterone undecanoate (injectable testosterone therapy)
Long‑acting testosterone replacement therapy for adult male hypogonadism confirmed by clinical features and biochemical tests.
Proton pump inhibitor (esomeprazole) formulations
Esomeprazole gastro‑resistant tablets and other formulations indicated for GERD, ulcer healing and H. pylori eradication regimens (indications vary by formulation and market).
Rosuvastatin (lipid‑lowering therapy)
Statin therapy for hypercholesterolaemia and prevention of major cardiovascular events in high‑risk patients (indications and dosing vary by market).
Services
Manufacturing of solid, semi‑solid and liquid dosage forms for internal products and external customers, including controlled drug handling and export services.
Support for regulatory compliance, pharmacovigilance reporting and regulatory documentation to support market authorisations and post‑approval obligations.
Business development and alliance management services covering in‑licensing, out‑licensing, acquisitions and commercial deals to expand portfolios and market reach.
Manufacturing of solid, semi‑solid and liquid dosage forms for internal products and external customers, including controlled drug handling and export services.
Support for regulatory compliance, pharmacovigilance reporting and regulatory documentation to support market authorisations and post‑approval obligations.
Business development and alliance management services covering in‑licensing, out‑licensing, acquisitions and commercial deals to expand portfolios and market reach.
Expertise Areas
- Pain-focused drug discovery and development
- Clinical trial design and management (Phase I–III)
- Regulatory affairs and compliance
- GMP manufacturing and contract manufacturing
Key Technologies
- Topical high‑concentration capsaicin formulation (8% patch)
- Transdermal polymer‑matrix patch technology
- Nociceptin receptor agonist pharmacology (NOP)
- Resiniferatoxin intra‑articular therapy (RTX)
News & Updates
Highlighting Grünenthal’s advanced production facilities worldwide that reached 177 million packs of medicines in 2024.
Showcasing opportunities for personal and professional growth within the company.
Grünenthal's engagement at Europe's largest pain management congress.
The company's support for work-life balance through its company daycare since 2015.
Details on Grünenthal’s sustainability and corporate responsibility efforts.
Grünenthal is a global leader in pain management.
An overview of Grünenthal's mission, vision, and global operations, emphasizing its commitment to innovation and patient care.
Highlighting Grünenthal’s advanced production facilities worldwide that reached 177 million packs of medicines in 2024.
Showcasing opportunities for personal and professional growth within the company.
Grünenthal's engagement at Europe's largest pain management congress.
The company's support for work-life balance through its company daycare since 2015.
Details on Grünenthal’s sustainability and corporate responsibility efforts.
Grünenthal is a global leader in pain management.
An overview of Grünenthal's mission, vision, and global operations, emphasizing its commitment to innovation and patient care.